A drug that has been available for 40 years is a...

The study, published in the journal “Scientific Reports”, said that the drug “Probenecid” has antiviral properties, which makes it a prime candidate to combat not only the emerging corona infection, but also other deadly respiratory viruses such as human respiratory syncytial virus (RSV) and influenza.

Probenecid has been available for about 40 years in the pharmaceutical market, and it is also approved by the US Food and Drug Administration and is primarily used to treat gout, and is widely available in the United States, as it has few side effects.Ralph Tripp, lead author of the study and researcher of vaccines and therapeutic studies, stated that this antiviral works with all respiratory viruses that we have tested, including human respiratory syncytial virus (RSV), influenza, and the emerging corona, which means that you can reduce infection and disease with this drug. Oral.

The researchers found that the drug “Probenecid” is a preventive method before exposure to the virus, and it is also a treatment after exposure to the emerging corona and influenza, and the effectiveness of the drug in fighting the human respiratory syncytial virus (RSV) has also been proven in the laboratory.Health workers can take medication to prevent disease. Probenecid is widely available, and primary care doctors can prescribe it to patients, and they can get it easily from pharmacies.

It is noteworthy that it is common to reuse approved drugs to solve some problems. Remdesivir was originally intended to fight the Ebola virus, but when it showed some hope in fighting the emerging corona, it was recruited into the war against the virus.

The researchers suggested that probenecid would increase the effectiveness of other treatments, as it is already used to increase the effectiveness of some antibiotics, so it is possible that the drug works in conjunction with other (Covid-19) treatments as well.

These were the details of the news A drug that has been available for 40 years is a... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

Author Information

I am Joshua Kelly and I focus on breaking news stories and ensuring we (“Al-KhaleejToday.NET”) offer timely reporting on some of the most recent stories released through market wires about “Services” sector. I have formerly spent over 3 years as a trader in U.S. Stock Market and is now semi-stepped down. I work on a full time basis for Al-KhaleejToday.NET specializing in quicker moving active shares with a short term view on investment opportunities and trends. Address: 838 Emily Drive Hampton, SC 29924, USA Phone: (+1) 803-887-5567 Email: [email protected]